Promoter holding
64.27%
CL
Consytel Life Sciences Private Limited - Due diligence report
A 360° intelligence report on Consytel Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, gro…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Consytel Life Sciences Private Limited — 360° Intelligence Report
Generated from MCA filings & public records79/100
Trust Score
Low Risk
Consytel Life Sciences Private Limited is assessed as Low Risk with a Trust Score of 79/100. Consytel Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2017, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 17 Aug 2026 from the latest processed filings. Consytel Life Sciences Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
79/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
55/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 1 open (11.30 Lakh) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Uco Bank | 1 | 48.0 cr |
Compliance Score: 100/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SWAGATIKA SATPATHY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SAURABH DASH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANDHYARANI DASH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHUBHENDU KUMAR DASH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 70 · Distress 60
Growth signals & trust indicators
Profit expanded 1.42 year-on-year.
Asset base grew 2.1x - capacity expansion.
Net margin improved to 24%.
Operating for 8 years.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 0.86 in a year.
Negative net worth.
1 open charge(s) registered - assets are encumbered.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment66/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 11.30 Lakh already registered.
- Compliance record supports lending.
Investor view67/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 8 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
04 Nov 2022
Director appointed
SAURABH DASH (Director)
27 Jul 2020
Charge created
Uco Bank - 11.30 Lakh
01 Nov 2019
Director appointed
SWAGATIKA SATPATHY (Director)
22 Dec 2017
Incorporated
Registered with Roc Hyderabad
Director appointed
SANDHYARANI DASH (Director)
Director appointed
SHUBHENDU KUMAR DASH (Director)
10
Key Observations
Auto-generated from the data aboveCompliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
| Company | CIN | Location |
|---|---|---|
| Frichem Private Limited | U99999MH1996PTC100017 | Mumbai, Maharashtra, India |
| Arka Medical Devices Private Limited | U24304TG2017PTC121124 | Ranga Reddy, Telangana, India |
| Roots And Herbs India Pvt Ltd | U01119MH1987PTC044147 | Khed, Maharashtra, India |
| Phlox Laboratories Private Limited | U24232UP1993PTC014984 | Lucknow, Uttar Pradesh, India |
| Biotech Pest Control (India) Private Limited | U24110TG1992PTC014136 | Secunderabad, Telangana, India |
| Aa Resources & Trading Private Limited | U24230MP2008PTC020554 | Indore, Madhya Pradesh, India |
| Orion Organics Pvt Ltd | U24231PB1991PTC011261 | Punjab, Punjab, India |
| Rockwell Plastics Private Limited | U24299HR1996PTC079584 | Haryana, Haryana, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Consytel Life Sciences Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Consytel Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Consytel Life Sciences Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 79/100, distress signals and MSME payment-delay disclosures - know whether Consytel Life Sciences Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Consytel Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Consytel Life Sciences Private Limited an active company?
Consytel Life Sciences Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).
Is Consytel Life Sciences Private Limited financially healthy?
Consytel Life Sciences Private Limited has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.
Should I do business with Consytel Life Sciences Private Limited?
Its overall Trust Score is 79/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Consytel Life Sciences Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.
Does Consytel Life Sciences Private Limited have loans or charges against its assets?
1 open charge(s) are registered against its assets.
Is Consytel Life Sciences Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).
Is it risky to lend to Consytel Life Sciences Private Limited?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
